流动注射分析法测定醋酸泼尼松片含量均匀度的研究

根据蓝四氮唑与泼尼松生成蓝色产物,并于525nm 波长处测定吸光度。测定条件为:反应管长度为3.8m(0.5mm id);流速为1.6ml/min;反应温度为55±0.5℃;注射样品溶液为100μl;本测定系统的测定速度可达100次/h;线性范围可达0.09mg/ml;检测限量为1.54μg/ml;测定结果的变异系数小于1%。     

药用淀粉生产工艺改进研究

用十二烷基硫酸钠或十二烷基磺酸钠与亚硫酸的混合液浸泡玉米，能有效地降低玉米淀粉中的蛋白质含量，较单独用亚硫酸浸泡，所得玉米淀粉的蛋白质含量可分别降低４０％和３５％。     

分光光度法测定抗风痛胶囊中总生物碱的含量

目的：采用分光光度法对抗风痛胶囊中总生物碱进行含量测定。方法：采用将生物碱变成盐酸生物碱，再和溴麝香草酚蓝络合反应后，用氯仿萃取出总生物碱比色测定。结果：与HPLC法测定结果相比，分光光度法对抗风痛胶囊中总生物碱进行含量测定结果可靠。结论：本方法能够作为抗风痛胶囊质量控制方法之一。     

高效液相色谱法测定去氧氟尿苷含量及其有关物质

目的 用高效液相色谱法（HPLC法）测定去氧氟尿苷的含量及其有关物质。方法 采用Diamonsil C—粒（250mm×4．6mm，5μm），流动相为乙腈-水（1：1），检测波长为269nm，流速为0．8mL／min。结果 去氧氟尿苷质量浓度在10．0～200．4μg／mL范围内与峰面积线性关系良好，r：0．9999（n：5），平均回收率为100．2％，RSD=0．14％。结论 HPLC法简便、准确，专属性好，灵敏度高，可用于去氧氟尿苷含量及有关物质的测定。     

原子荧光法测定氯化氨基汞软膏中汞含量

目的建立氯化氨基汞软膏中汞的含量测定方法。方法利用HCIO4-HNO，湿法消解，对氯化氨基汞软膏中汞进行原子荧光测定。结果汞线性范围是1．0000～8．0000μg／L，r=0．9995，平均加样回收率为98．17％，RSD=0．2％（n=9）。结论所用方法简单、结果准确、灵敏度高，可有效控制氯化氨基汞软膏的质量。     

Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors

Current clinical staging, which includes the use of serum tumor markers and imaging techniques, fails to identify the 30–40% of clinical stage I (CS I) nonseminomatous germ cell testicular tumor (NSGCT) patients who have occult metastatic disease. Therefore, there is a real clinical need to evaluate new biological parameters of the primary tumor that might be useful as predictors of occult metastatic disease. This study was undertaken to compare quantitative DNA measurements by flow cytometry and image analysis in CS I NSGCT, and to analyze the relevance of these parameters for predicting occult lymph node involvement. Different blocks of formalin-fixed, paraffin-embedded NSGCTs of 62 CS I patients who underwent retroperitoneal lymph node dissection between 1985 and 1989 were prepared according to the Hedley technique, and analyzed by quantitative cytometry. Thirty-six (58.1%) patients had histologically proven lymph node involvement (pathological stage II), whereas 26 (41.9%) patients (pathological stage I) had neither lymph node metastases according to retroperitoneal lymph node dissection (RPLND) specimens nor tumor recurrence during follow-up. Concordant results were found in 76.5% of the samples by both cytometric techniques. For flow cytometry, the percentages of aneuploid cells in the S- and the G2M+S-phase were the most robust predictive parameters for lymph node involvement, whereas for image analysis the 5c exceeding rate (5cER) had the most predictive significance. Based on the experience obtained in this study, both cytometric techniques provide additional information on tumor aggressiveness that might be useful in therapeutic selection of early stage NSGCT patients for either RPLND or surveillance only.     

乳腺囊性增生病癌变过程中部分因素变化的意义

检测乳腺囊性增生病（ＦＣＤ）经不典型增生到癌变部分因素的变化。结果提示：从因明显ＦＣＤ症状活检至癌变为２～１０年；从Ⅱ级以上不典型增生到临床癌变需２～７年；癌变率为３．１％。ＦＣＤ患者存在性激素分泌调控失常，血浆雌激素和催乳素含量增加，导致上皮细胞增生。乳腺一般性增生细胞的ＤＮＡ含量和超微结构与正常乳腺上皮细胞相似；无肿瘤相关抗原及异常基因产物表达。而发生在一般性增生基础上的不典型增生则呈现细胞基因物质ＤＮＡ含量增加，部分为超４Ｃ的多倍体细胞；同时出现细胞膜和细胞核超微结构异常；雌激素受体含量增加，对性激素的依赖性和敏感性增强；部分不典型增生细胞出现胚胎性肿瘤相关抗原和异常基因产物表达。随不典型增生程度加重至乳腺癌，上述诸因素的变化趋势具有明显规律性。提示ＦＣＤ上皮细胞从一般性增生经不典型增生至乳腺癌为细胞生物学连续逐渐变化的过程。部分不典型增生细胞中具有癌倾向的细胞生物学行为异常和表型变化与乳腺癌发生密切相关。细胞核ＤＮＡ含量等异常变化及程度可作为乳腺癌前病变发展程度的客观标志     

茶叶多糖的研究进展

茶叶多糖是一种复合杂多糖，具有许多生物活性。作者系统地介绍了茶叶多糖的提取、分离、纯化、纯度鉴定及相对分子质量测定的方法，以及其含量和组成、理化性质、化学结构及空间构象、生物活性等方面的研究进展，并对上述方法及研究进展进行了分析和评述。     

人参银杏合剂对模拟海拔8000米低氧大鼠的保护作用研究

目的 :研究人参银杏合剂对模拟海拔 80 0 0米低氧大鼠脑组织及血液内丙二酰二甲醛 (MDA)、乳酸含量的影响 ,并探讨其机理。方法 :用成年 SD大白鼠随机分为常氧对照组 (NC组 ) ,急性低氧组 (AH组 ) ,人参银杏合剂加低氧组 (GH组 ) ;分别测定各组的脑含水量、脑组织和血液 MDA和乳酸的含量。结果 :(1)与 NC组相比 ,AH组的脑含水量明显增高 (P<0 .0 1) ,GH组脑含水量较 AH组显著降低 (P<0 .0 5 )。(2 ) AH组脑组织匀浆和血液 MDA含量明显高于 NC组 (P<0 .0 1) ,GH组的 MDA含量较 AH组显著降低 (P<0 .0 1)。 (3) AH组脑组织匀浆和血液乳酸含量明显高于 NC组 (P<0 .0 1) ,GH组的乳酸含量较 AH组显著降低 (P<0 .0 1)。结论 :人参银杏合剂对高原缺氧脑损伤具有保护作用 ,其机理与其抗氧自由基、与膜脂质过氧化作用、改善细胞能量代谢有关。     

Body mass index, percent body fat, and bone mass in a cohort of Chinese twins aged 6 to 18 years

Introduction This report examines the relationship of body mass index (BMI), percent body fat (%BF), and bone mass in a cohort of male and female twins recruited from Anhui province, China, ages 6–18 years—577 male pairs (mean age = 11.4) and 478 female pairs (mean age = 11.6). Methods Whole body bone mineral content (WBMC) in (g), whole body bone area (WBA) in (cm²), and %BF were measured using DEXA (Lunar Prodigy, USA). Regression analysis of within-pair differences was used to assess the strength of the association, and the analysis was stratified by gender and age group, where age cut-offs were based on ages at spermarche or menarche estimated from large population based studies in China. Males were stratified at ages before 14 and age 14–18, and females at ages prior to 12 and age 12–18. Results Univariately, BMI and %BF were associated with WBMC and WBA in the younger males and females, and in older males; %BF was significant only in older females. Multivariate models included both BMI and %BF. Among the younger males, age < 14, BMI and %BF were significantly associated with WBMC and WBA. In the younger females, age < 12, %BF was only significant to WBA. In the older age group, only BMI was significant to WBMC and WBA in females, but in males, BMI was positively associated, and %BF was negatively associated with both bone measures. Discussion These findings show that association between BMI and %BF and bone mass differ across gender and developmental stages, and %BF appears to be beneficial at younger ages, but detrimental or non-beneficial at older ages of development.